Foghorn Therapeutics Inc. (FHTX) revenue

Revenue · fiscal 2025
$30.91M

Foghorn Therapeutics Inc. (FHTX) reported revenue of $30.91M in fiscal 2025 (the year ended December 31, 2025). That is 36.8% higher than the $22.60M of fiscal 2024. Figures as of 18 Nov 2026, 12:48 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$30.91M
Change on fiscal 2024
+36.8%
Growth, 5 years
+135.1% a year
Highest on record
$34.16Mfiscal 2023
Lowest on record
$430.00Kfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Foghorn Therapeutics Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 135.1% a year. Across the 6 fiscal years on record (2020–2025), the highest was $34.16M in fiscal 2023 and the lowest $430.00K in fiscal 2020.

History · 6 fiscal years

Revenue by fiscal year

Foghorn Therapeutics Inc. revenue, year by year

Foghorn Therapeutics Inc. (FHTX) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$30.91M 36.8% up
2024$22.60M 33.8% down
2023$34.16M 77.6% up
2022$19.23M 1,357.8% up
2021$1.32M 206.7% up
2020$430.00K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on FHTX

Foghorn Therapeutics Inc., figure by figure

Foghorn Therapeutics Inc. (FHTX) overview: price, valuation and scorecard

Foghorn Therapeutics Inc. revenue: questions and answers

What is Foghorn Therapeutics Inc.'s revenue?

Foghorn Therapeutics Inc. (FHTX) reported revenue of $30.91M in fiscal 2025 (the year ended December 31, 2025). That is 36.8% higher than the $22.60M of fiscal 2024.

What is the growth rate of Foghorn Therapeutics Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 135.1% a year.

What are the highest and lowest revenue figures on record for Foghorn Therapeutics Inc.?

Across the 6 fiscal years on record (2020–2025), the highest was $34.16M in fiscal 2023 and the lowest $430.00K in fiscal 2020.

How is Foghorn Therapeutics Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Foghorn Therapeutics Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Foghorn Therapeutics Inc. (FHTX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/FHTX/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.